Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,805 products)
- Chiral Building Blocks(1,248 products)
- Hydrocarbon Building Blocks(6,118 products)
- Organic Building Blocks(61,447 products)
Found 208423 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-Aminohexan-1-ol hydrochloride
CAS:Versatile small molecule scaffoldFormula:C6H16ClNOPurity:Min. 95%Molecular weight:153.65 g/mol{2-Benzyl-8-oxa-2-azaspiro[4.5]decan-4-yl}methanamine
CAS:Versatile small molecule scaffoldFormula:C16H24N2OPurity:Min. 95%Molecular weight:260.37 g/mol2-Methoxy-2-(oxan-4-yl)acetaldehyde
CAS:Versatile small molecule scaffold
Formula:C8H14O3Purity:Min. 95%Molecular weight:158.19 g/mol2-Amino-3-carbamoylbenzoic acid
CAS:Versatile small molecule scaffold
Formula:C8H8N2O3Purity:Min. 95%Molecular weight:180.16 g/mol2-Fluoro-2-(pyrrolidin-3-ylidene)ethan-1-ol
CAS:Versatile small molecule scaffold
Formula:C6H10FNOPurity:Min. 95%Molecular weight:131.15 g/molAPhos Pd G3
CAS:APhos Pd G3 is a drug with a bicyclic structure. It is an inhibitor of ganglion cells and has been shown to have a positive effect on the symptoms of dementia, psychosis, and psychiatric disorders. It has also been shown to be beneficial in the treatment of Parkinson's disease, which is characterized by the loss of dopaminergic neurons. APhos Pd G3 prevents neuronal cell death by inhibiting monoamine oxidase-B (MAO-B), which breaks down dopamine. This leads to increased levels of dopamine in the striatum and improved motor function. APhos Pd G3 also blocks MAO-A, which breaks down serotonin, norepinephrine, and epinephrine. The inhibition of MAO-A leads to increased levels of serotonin and norepinephrine in the brainstem and spinal cord.Formula:C29H41N2O3PPdSPurity:Min. 95%Molecular weight:635.11 g/mol1-Hydrazinyl-2-methylpropan-2-ol hydrochloride
CAS:Versatile small molecule scaffoldFormula:C4H13ClN2OPurity:Min. 95%Molecular weight:140.61 g/mol6-(1H-1,2,4-Triazol-3-yl)pyridine-3-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C8H6N4O2Purity:Min. 95%Molecular weight:190.16 g/mol6-aminospiro[3.3]heptan-2-ol hydrochloride
CAS:Versatile small molecule scaffoldFormula:C7H14ClNOPurity:Min. 95%Molecular weight:163.65 g/mol2-tert-Butyl-5-(iodomethyl)-4,5-dihydro-1,3-oxazole
CAS:Versatile small molecule scaffold
Formula:C8H14INOPurity:Min. 95%Molecular weight:267.11 g/mol2,4-Dimethylpentane-3-thiol
CAS:Versatile small molecule scaffoldFormula:C7H16SPurity:Min. 95%Molecular weight:132.27 g/mol2-Bromo-5H,6H,7H,8H,9H,10H,11H-cycloocta[b]indole
CAS:Versatile small molecule scaffoldFormula:C14H16BrNPurity:Min. 95%Molecular weight:278.19 g/mol1-Phenylcyclopropanesulfonamide
CAS:1-Phenylcyclopropanesulfonamide (PCPS) is a drug that binds to the P2Y12 receptor and inhibits platelet aggregation. It has been shown to be effective in reducing bleeding time, which may be due to its ability to inhibit the activation of thrombin. PCPS also has antithrombotic properties, and has been shown to inhibit collagen-induced platelet aggregation. This drug also binds to the P2Y12 receptor with high affinity, but it does not have any effect on agonist-mediated responses.Formula:C9H11NO2SPurity:Min. 95%Molecular weight:197.26 g/mol1-Azabicyclo[2.2.1]heptane-7-carboxylic acid hydrochloride
CAS:Versatile small molecule scaffoldFormula:C7H12ClNO2Purity:Min. 95%Molecular weight:177.63 g/moltert-Butyl 4-(carbamoylamino)piperidine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C11H21N3O3Purity:Min. 95%Molecular weight:243.3 g/molN-[3,5-Bis(trifluoromethyl)phenyl]-2-bromopropanamide
CAS:Versatile small molecule scaffoldFormula:C11H8BrF6NOPurity:Min. 95%Molecular weight:364.08 g/mol6-Bromo-7-methylquinoxaline
CAS:6-Bromo-7-methylquinoxaline is a halogenated aromatic compound that can be used as an oxidizing agent. It reacts with the methyl group of dimethylbenzene to form a chlorinated product. 6-Bromo-7-methylquinoxaline also reacts with bisulphite to form peracetic acid. This chemical may also be used in the synthesis of quinoxalines by reacting with diamino. 6-Bromo-7-methylquinoxaline is oxidized by hydrogen peroxide to form the glyoxal and peroxide products, which are then reacted with methylquinaldine to produce diamino and quinoxalines.Formula:C9H7BrN2Purity:Min. 95%Molecular weight:223.08 g/mol1-(2-Methylbut-3-yn-2-yl)-1H-pyrrole
CAS:Versatile small molecule scaffoldFormula:C9H11NPurity:Min. 95%Molecular weight:133.19 g/mol(1-Methyl-1,2,3,4-tetrahydroquinolin-4-yl)methanamine
CAS:Versatile small molecule scaffoldFormula:C11H16N2Purity:Min. 95%Molecular weight:176.26 g/mol2-Methyl-4-{[(oxan-2-ylmethyl)amino]methyl}aniline
CAS:Versatile small molecule scaffoldFormula:C14H22N2OPurity:Min. 95%Molecular weight:234.34 g/mol
